Eldobi Capsule (Erdostein)

Adult dose

Adults: Administer 300 mg of erdosteine per dose orally 2～3 times daily. When used for acute respiratory diseases, do not administer continuously for more than 10 days.

This medication should not be used in certain patients. Firstly, individuals allergic to this medication or its components should not take it. Patients with liver cirrhosis or cystathionine synthase deficiency should avoid this medication because its metabolites may affect methionine metabolism in the body. Additionally, patients with peptic ulcers, severe renal impairment, and significant liver function disorders should not take this medication. This drug contains lactose monohydrate, so it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with mild to moderate liver impairment should be cautious when using this medication and should not exceed a daily dose of 300 mg. Diabetics or those on a low-calorie diet should be particularly careful when using the syrup formulation. Furthermore, this medication contains the dye Tartrazine (Yellow No. 5), so patients allergic or sensitive to this component should use it cautiously. Overdose of this medication may cause symptoms such as sweating, dizziness, flushing of the face. Gastrointestinal symptoms including headache, cold symptoms, shortness of breath, taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn have also been reported. Skin reactions such as hives, erythema, and eczema may occur. Post-marketing surveillance in domestic use has reported symptoms like fatigue, indigestion, palpitations, facial and generalized edema, itching, weakness, and drowsiness. Care should be taken when this medication is taken alongside expectorants, as it may increase the risk of bronchial infections due to difficulty in expelling phlegm caused by the alleviation of cough. It is advisable for pregnant women or those who may become pregnant, as well as nursing mothers, not to take this medication since its safety has not been adequately confirmed. Lastly, this medication should be kept out of reach of children, and transferring it to another container is not recommended for maintaining quality and safety.

sweating

Drug interactions

Caution should be exercised when this medication is taken in conjunction with cough medicines.

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance

A hard capsule with green upper part and yellow lower part containing white powder.

Package unit

30 capsules/bottle, 300 capsules/bottle